Viewing StudyNCT00138554



Ignite Creation Date: 2024-05-05 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00138554
Status: COMPLETED
Last Update Posted: 2017-02-23
First Post: 2005-08-27

Brief Title: Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 Diabetes
Sponsor: Novartis
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Diabetes Mellitus Type 2
Keywords:
Name View
vildagliptin View
Type 2 diabetes View